Published in

Wiley, Artificial Organs, 5(46), p. 932-952, 2021

DOI: 10.1111/aor.14148

Links

Tools

Export citation

Search in Google Scholar

HEROES V‐V—HEmorRhagic cOmplications in Veno‐Venous Extracorporeal life Support—Development and internal validation of multivariable prediction model in adult patients

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractBackgroundDuring extracorporeal life support (ECLS), bleeding is one of the most frequent complications, associated with high morbidity and increased mortality, despite continuous improvements in devices and patient care. Risk factors for bleeding complications in veno‐venous (V‐V) ECLS applied for respiratory support have been poorly investigated.We aim to develop and internally validate a prediction model to calculate the risk for bleeding complications in adult patients receiving V‐V ECLS support.MethodsData from adult patients reported to the extracorporeal life support organization (ELSO) registry between the years 2010 and 2020 were analyzed. The primary outcome was bleeding complications recorded during V‐V ECLS. Multivariable logistic regression with backward stepwise elimination was used to develop the predictive model. The performance of the model was tested by discriminative ability and calibration with receiver operating characteristic curves and visual inspection of the calibration plot.ResultsIn total, 18 658 adult patients were included, of which 3 933 (21.1%) developed bleeding complications. The prediction model showed a prediction of bleeding complications with an AUC of 0.63. Pre‐ECLS arrest, surgical cannulation, lactate, pO2, HCO3, ventilation rate, mean airway pressure, pre‐ECLS cardiopulmonary bypass or renal replacement therapy, pre‐ECLS surgical interventions, and different types of diagnosis were included in the prediction model.ConclusionsThe model is based on the largest cohort of V‐V ECLS patients and reveals the most favorable predictive value addressing bleeding events given the predictors that are feasible and when compared to the current literature. This model will help identify patients at risk of bleeding complications, and decision making in terms of anticoagulation and hemostatic management.